» Articles » PMID: 39778871

An Immunohistochemical Study of Thanatophoric Dysplasia Type 1 After Fetus Autopsy Examination

Overview
Date 2025 Jan 8
PMID 39778871
Authors
Affiliations
Soon will be listed here.
Abstract

The current case report presents the postmortem examination findings of a 17-week-old female fetus displaying thanatophoric dysplasia type 1 (TD-1) due to a known fibroblast growth factor receptor 3 (FGFR3) gene mutation. Gross and X-ray examination revealed significant abnormalities, including skeletal malformations with prominent TD-1 femur curvature. Microscopical evaluation indicated inadequate histological growth for the gestational age, with specific organ immaturity noted in multiple hematoxylin and eosin sections from internal organs, bone from epiphyses and diaphyses levels. Immunohistochemical analysis was conducted using specific markers, such as S100, CD34, CD117, glycophorin-C, and myeloperoxidase, to identify various hematopoietic and mesenchymal cell types. Furthermore, this report underscores the often-overlooked aspect of fetal hematopoiesis in cases diagnosed with TD-1, shedding light on the development of hematopoietic cells and their markers in various tissues, with a particular emphasis on the investigation of bone marrow foci in areas with incipient or no apparent ossification. Immunohistochemical identification of hematopoiesis also served as an indirect way to identify areas of incipient or abnormal ossification.

Citing Articles

An immunohistochemical study of thanatophoric dysplasia type 1 after fetus autopsy examination.

Abba Deka I, Theotokis P, Manthou M, Mathioudi A, Athanasiou E, Meditskou S Congenit Anom (Kyoto). 2025; 65(1):e70004.

PMID: 39778871 PMC: 11710925. DOI: 10.1111/cga.70004.

References
1.
Liu W, Cao J, Shi X, Li Y, Qiao F, Wu Y . Genetic testing and diagnostic strategies of fetal skeletal dysplasia: a preliminary study in Wuhan, China. Orphanet J Rare Dis. 2023; 18(1):336. PMC: 10599061. DOI: 10.1186/s13023-023-02955-4. View

2.
Waratani M, Ito F, Tanaka Y, Mabuchi A, Mori T, Kitawaki J . Prenatal diagnosis of fetal skeletal dysplasia using 3-dimensional computed tomography: a prospective study. BMC Musculoskelet Disord. 2020; 21(1):662. PMC: 7545947. DOI: 10.1186/s12891-020-03663-x. View

3.
He D, Tang X, Dong W, Cui G, Peng G, Yin X . C-KIT Expression Distinguishes Fetal from Postnatal Skeletal Progenitors. Stem Cell Reports. 2020; 14(4):614-630. PMC: 7160391. DOI: 10.1016/j.stemcr.2020.03.001. View

4.
Strobl H, Takimoto M, Majdic O, Fritsch G, Scheinecker C, Hocker P . Myeloperoxidase expression in CD34+ normal human hematopoietic cells. Blood. 1993; 82(7):2069-78. View

5.
Balounova J, Splichalova I, Dobesova M, Kolar M, Fiser K, Prochazka J . Toll-like receptor 2 expression on c-kit cells tracks the emergence of embryonic definitive hematopoietic progenitors. Nat Commun. 2019; 10(1):5176. PMC: 6858454. DOI: 10.1038/s41467-019-13150-0. View